Search - tctmd.com

Displaying 301 - 320 of 1342

Sort: Relevancy | Date

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

Presentation TCT 2023

Important Secondary Endpoints From the PARTNER 3 5-YEAR STUDY

Presenter: Raj Makkar

October 24, 2023

Presentation TCT 2023

Perspectives on Mortality in the PARNTER 5-Year Study

Presenter: Vinod Thourani

October 24, 2023

Presentation TCT 2023

One-Year Outcomes after Amulet or Watchman/FLX Device for Percutaneous Left Atrial Appendage Closure: a Pre-Specified Analysis of the SWISS-APERO Randomized Clinical Trial

Presenter: Roberto Galea

October 24, 2023

News Conference News TCT 2023

WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone

Todd Neale

October 24, 2023

Presentation TCT 2023

Tendyne SUMMIT Pivotal Trial Roll-In and MAC Arm Outcomes

Presenter: Jason Rogers

October 24, 2023

Presentation TCT 2023

Five-year Echocardiographic Outcomes From The PARTNER 3 Low-risk Randomized Trial

Presenter: Rebecca Hahn

October 24, 2023

Presentation TCT 2023

ALIGN-AR Trial: Initial Outcomes of the JenaValve Trilogy Transcatheter Aortic Valve Replacement in High Risk Patients With Symptomatic Severe Native Aortic Regurgitation

Presenter: Vinod Thourani

October 24, 2023

Presentation TCT 2023

Safety and Efficacy of Left Atrial Appendage Occlusion at the Time of Transcatheter Aortic Valve Replacement - WATCH TAVR Trial Results

Presenter: Samir Kapadia

October 24, 2023

Presentation TCT 2023

Four-Year Outcomes From the EVOLUT Low Risk Trial

Presenter: Michael Reardon

October 24, 2023

Presentation TCT 2023

Five-Year Clinical and Echocardiographic Outcomes From The PARTNER 3 Low-Risk Randomized Trial

Presenter: Martin Leon

October 24, 2023

Presentation TCT 2023

TCT 269: Association Between Nickel Hypersensitivity and Device Syndrome After Patent Foramen Ovale Closure in Female Patients: Preliminary Results of a Randomized Trial

Presenter: Anastasios Apostolos

October 24, 2023

Presentation TCT 2023

Balloon- vs. Self-Expanding valve systems for failed small surgical aortic valve bioprostheses: 1-year results of the LYTEN trial

Presenter: Jorge Nuche

October 23, 2023

Presentation TCT 2023

Dual ProGlide versus ProGlide and AngioSeal for Hemostasis at the Femoral Access after Transcatheter Aortic Valve Replacement: A Randomized Comparative Trial

Presenter: Chih-Fan Yeh

October 23, 2023

Presentation TCT 2023

Pulmonary Artery Denervation for Group II Pulmonary Hypertension: Updates from Ongoing Clinical Trials in China

Presenter: ShaoLiang Chen

October 23, 2023

News Daily News

SAVR 5-Year Survival Tops 92% in Low-Risk Patients: STS Registry

Yael L. Maxwell

October 20, 2023

News Opinion Editor's Corner

What’s Going to Be Hot at TCT 2023

Shelley Wood

October 19, 2023

News Conference News EACTS 2023

AUTHEARTVISIT Reignites RCT vs Real-world Data Debate for AV Repair

Michael O'Riordan

October 09, 2023

News Conference News EACTS 2023

SWEDEHEART Hints at Mortality Benefit With Statins After SAVR

Michael O'Riordan

October 05, 2023

News Daily News

TCTMD’s Top 10 Most Popular Stories for September 2023

Shelley Wood

October 03, 2023

Advertisement

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Important Secondary Endpoints From the PARTNER 3 5-YEAR STUDY

Perspectives on Mortality in the PARNTER 5-Year Study

One-Year Outcomes after Amulet or Watchman/FLX Device for Percutaneous Left Atrial Appendage Closure: a Pre-Specified Analysis of the SWISS-APERO Randomized Clinical Trial

WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone

Tendyne SUMMIT Pivotal Trial Roll-In and MAC Arm Outcomes

Five-year Echocardiographic Outcomes From The PARTNER 3 Low-risk Randomized Trial

ALIGN-AR Trial: Initial Outcomes of the JenaValve Trilogy Transcatheter Aortic Valve Replacement in High Risk Patients With Symptomatic Severe Native Aortic Regurgitation

Safety and Efficacy of Left Atrial Appendage Occlusion at the Time of Transcatheter Aortic Valve Replacement - WATCH TAVR Trial Results

Four-Year Outcomes From the EVOLUT Low Risk Trial

Five-Year Clinical and Echocardiographic Outcomes From The PARTNER 3 Low-Risk Randomized Trial

TCT 269: Association Between Nickel Hypersensitivity and Device Syndrome After Patent Foramen Ovale Closure in Female Patients: Preliminary Results of a Randomized Trial

Balloon- vs. Self-Expanding valve systems for failed small surgical aortic valve bioprostheses: 1-year results of the LYTEN trial

Dual ProGlide versus ProGlide and AngioSeal for Hemostasis at the Femoral Access after Transcatheter Aortic Valve Replacement: A Randomized Comparative Trial

Pulmonary Artery Denervation for Group II Pulmonary Hypertension: Updates from Ongoing Clinical Trials in China

SAVR 5-Year Survival Tops 92% in Low-Risk Patients: STS Registry

What’s Going to Be Hot at TCT 2023

AUTHEARTVISIT Reignites RCT vs Real-world Data Debate for AV Repair

SWEDEHEART Hints at Mortality Benefit With Statins After SAVR

TCTMD’s Top 10 Most Popular Stories for September 2023

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content